Navigation Links
Dr. Suwelack Skin & Health Care: New Product in the FDA Certification Process
Date:10/10/2007

"We Want to Double our Sales Within Three Years"

BILLERBECK, Germany, October 10 /PRNewswire/ -- With an increase in sales of EUR 3.4 million to EUR 17 million, Dr. Suwelack Skin & Health Care AG is still on the path of significant growth in 2007. "We want to increase our sales to EUR 30 million within three years," states CEO Nikolaus Uleer. With the construction of the largest pharmaceutical-standard production plant in the world, the biotech manufacturer has considerably expanded its activities.

The German biotech manufacturer earns 80 percent of its sales abroad, with the most significant growth in the USA - within one year, its Puracol dressing for chronic wounds has successfully competed against similar products. A second wound dressing is currently undergoing the FDA certification process.

Uleer regards the progress made with the European introduction of the collagen and elastic based biomatrix Matriderm as at least equal in significance to the successes on the US market. Surgeons implant Matriderm as a dermis replacement for the treatment of deep burn wounds. Says Uleer: "With an equity to assets ratio of 70 percent, the company is well-prepared for the international introduction of other medical products."

However: About 80 percent of international sales are in the cosmetics sector. International cosmetics companies implement their facial mask systems, and the major consumers are in Japan, Hong Kong and Germany. Regarding the objectives, Uleer explains: "Our product expertise has not yet been generally recognized, but we are seriously working on this. We intend to gain synergies from the latest scientific research in the medical and cosmetics fields and use these for product development."

Press contact:

excognito

Claudia-Maria Rohrer

Grossbeerenstrasse 28 c

10965 Berlin, Germany

Tel.: +49-30-887102-18

Fax: +49-30-887102-22

Email: claudia-maria.rohrer@excognito.de


'/>"/>
SOURCE Dr. Suwelack Skin & Health Care AG
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
2. Web-based reporting credited with states top healthcare ranking
3. Visions, Part II: Preizler sees IT leading incremental health system change
4. Visions: Preizler offers insurers perspective on healthcare IT
5. Federal bill would set healthcare IT standards
6. IRS ruling could speed healthcare technology adoption
7. Bill would provide federal aid for healthcare IT
8. Cardinal Health likes growth potential of Viasys NeuroCare Group
9. DHC 2007: Controlling health IT costs the key to capturing value
10. Siemens health services president calls IT benefits unassailable
11. DHC 2007: Without fuller IT adoption, health costs might drain Americas wealth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... DIEGO , Feb. 16, 2017  Dermata ... innovative products to treat a variety of dermatological ... million Series 1a financing and entered into a ... (SVB).  Dermata intends to use the capital for ... making major advancements in the treatment of serious ...
(Date:2/16/2017)... BOSTON , Feb. 16, 2017 /PRNewswire/ ... for rare genetic deficiencies that result in ... of a $41 million mezzanine round of ... Ipsen, OrbiMed, MPM Capital, New Enterprise Associates, ... an undisclosed public healthcare investment fund. Rhythm ...
(Date:2/15/2017)... CA (PRWEB) , ... February 15, 2017 , ... ... that Park SmartScan, a powerful AFM operating software that drastically boosts productivity with single ... completely automatizes all of the functions of setting up and taking the image once ...
(Date:2/15/2017)... , Feb. 15, 2017 Windtree ... biotechnology company focused on developing aerosolized KL4 surfactant ... has completed a $10.5 million private placement of ... it has sufficient capital to fund its operations ... trial data release in mid-2017. Windtree ...
Breaking Biology Technology:
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
Breaking Biology News(10 mins):